Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Voula – page 38

1 033 clinical trials in Voula, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GreeceOur site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)
Voula at a glance
1 033
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 033 trials in Voula

Open in trial search

Study on the Safety and Effectiveness of GFH925 and Cetuximab for Patients with Advanced Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Zhejiang Genfleet Therapeutics Co. Ltd.

Rheumatoid arthritis

Not yet recruiting

Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Peresolimab
  • Sponsor:Eli Lilly & Co.

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Acute myeloid leukaemia

Not yet recruiting

Study on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Servier Affaires Medicales

Pneumonia

Not yet recruiting

Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Cholesterol
  • Sponsor:Eagle Pharmaceuticals Inc.

Renal cell carcinoma

Not yet recruiting

Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Exelixis Inc.

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Sarcoidosis

Not yet recruiting

Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Xentria Inc.

Mantle cell lymphoma

Not recruiting

Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

Registered drug
Countries:GreeceGreece
  • Participants:65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Tendon disorder

Not recruiting

Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Colitis ulcerative

Not recruiting

Evaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Greece

The busiest research cities in the country

All 48 cities in Greece

Clinical research in Voula

What the registry says about research in the country

01 Autoimmune Disorders

Multiple clinical trials focusing on Sjögren's Syndrome and Systemic Lupus Erythematosus, evaluating new therapeutic approaches and treatment effectiveness.

  • Sibeprenlimab for Sjögren's Disease
  • Dazodalibep Studies
  • Belimumab for Early SLE

Research aims to improve systemic manifestations and patient-reported symptoms in these conditions.

02 Cardiovascular Medicine

Innovative trials exploring treatments for atrial fibrillation and acute myocardial infarction, with emphasis on stroke prevention and emergency interventions.

  • Stroke Prevention Studies
  • Acute Coronary Syndrome Treatment
  • Anticoagulation Therapies

Focus on developing safer and more effective treatments for cardiac conditions.

03 Critical Care Medicine

Advanced research in treating severe conditions including sepsis and candidemia, testing novel therapeutic approaches.

  • Emapalumab for Sepsis
  • Antifungal Treatments
  • Immune Response Studies

Investigations aim to improve survival rates and treatment outcomes in critical conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.